Skip to main content
. 2016 Sep 9;31(1):58–64. doi: 10.1038/leu.2016.219

Figure 1.

Figure 1

Schematic of UKALL14 treatment protocol. High risk features: karyotypes: t(9;22) t(4;11), low hypodiploidy near triploidy or complex, age >40 years, WBC ⩾30 × 109/l (precursor B lineage ALL), ⩾100 × 109/l (T-cell-ALL), molecular minimal residual disease positivity (>1 × 10−4) after induction phase 2.